FLT3 and acute myeloid leukemia: Mechanistically, ITD mutation results in constitutive activation of FLT3 signalling, which activates downstream kinases, including MAPK/ERK, JAK/STAT, and AKT, enhances cellular proliferation, and blocks apoptosis and differentiation in AML with FLT3 mutations4.